Intuitive Surgical INC Form 4 insider transactions

Intuitive Surgical's EVP & Chief Commercial and Marketing Officer, Henry L. Charlton, achieved performance criteria for two tranches of performance stock units, leading to future vesting of 10,043 shares.

Intuitive Surgical's EVP & CFO, Jamie Samath, reported the acquisition of performance stock units (PSUs) totaling 10,362 shares, with performance criteria achieved.

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, exercised stock options and subsequently sold the acquired common stock as part of a pre-arranged 10b5-1 trading plan.

Intuitive Surgical Director Gary S. Guthart exercised stock options and sold a portion of his shares, including those held in trusts, under a pre-arranged 10b5-1 trading plan.

Intuitive Surgical's SVP & Chief Mfg and Supply Chain Officer, Mark Brosius, sold 464 shares of common stock for $548.49 per share under a pre-arranged 10b5-1 trading plan.

Intuitive Surgical's SVP & Chief Mfg and Supply Chain Officer, Mark Brosius, filed an amended Form 4 to correct details of a common stock sale.

Intuitive Surgical's SVP & Chief Manufacturing and Supply Chain, Mark Brosius, reported the exercise of stock options and subsequent sale of common stock under a pre-arranged 10b5-1 trading plan.

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, exercised stock options and subsequently sold an equal number of common shares under a pre-arranged plan.

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, exercised stock options and sold an equal number of shares under a pre-arranged 10b5-1 trading plan.

Intuitive Surgical's Executive Chair, Gary S. Guthart, exercised stock options and subsequently sold a portion of the acquired common stock under a Rule 10b5-1 trading plan.

Intuitive Surgical's EVP & Chief Commercial and Marketing Officer, Henry L. Charlton, executed a series of option exercises and subsequent stock sales totaling 13,731 shares under a Rule 10b5-1 plan.

Intuitive Surgical Director Craig H. Barratt exercised stock options and sold the resulting shares under a Rule 10b5-1 plan.

Intuitive Surgical Director Keith R. Leonard gifted 1,606 shares of common stock to a Charitable Remainder Unitrust on November 12, 2025.

Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, executed a pre-planned sale of 105 common shares after exercising stock options.

Intuitive Surgical's EVP & Chief Digital Officer, Brian Miller, exercised stock options and sold an equivalent number of common shares under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical's VP Corporate Controller, Fredrik Widman, reported the exercise and sale of common stock and options under a Rule 10b5-1 trading plan.

Intuitive Surgical CEO David J. Rosa reported a planned gift of 5,454 shares of common stock to a donor-advised fund on November 3, 2025.

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, executed sales of common stock totaling 7,687 shares through option exercises under a Rule 10b5-1 plan.

Intuitive Surgical's Executive Chair, Gary S. Guthart, exercised stock options and subsequently sold a significant number of shares under a pre-arranged trading plan.

Intuitive Surgical Director Craig H. Barratt executed a pre-planned sale of 2,193 common shares after exercising stock options.

Intuitive Surgical CEO David J. Rosa exercised stock options and sold a portion of his common stock holdings under a pre-arranged trading plan.

Intuitive Surgical's EVP & Chief Legal and Compliance Officer, Gary Loeb, reported the vesting of 2,612 Restricted Stock Units and the subsequent sale of 1,296 shares for tax obligations.

Intuitive Surgical Director Amy L. Ladd sold 671 shares of common stock in early September 2025, executed under a pre-arranged 10b5-1 trading plan.

Intuitive Surgical's Executive Chair, Gary S. Guthart, executed a pre-planned transaction, exercising stock options and selling a portion of the resulting shares.

Intuitive Surgical's Executive Chair, Gary S. Guthart, executed stock options, sold common stock, and donated shares under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, completed a pre-arranged transaction, exercising stock options and selling an equal number of common shares.

Intuitive Surgical, Inc. has disclosed a grant of 7,640 Restricted Stock Units to its Chief Executive Officer, David J. Rosa, as part of his compensation.

Intuitive Surgical's President and Director, David J. Rosa, reported the vesting of 1,358 Restricted Stock Units (RSUs) and the subsequent disposition of 674 shares to cover tax obligations on June 10, 2025.

Mark Brosius, SVP & Chief Manufacturing and Supply Chain at Intuitive Surgical Inc., reported the sale of 431 shares of common stock in early June 2025 through a pre-scheduled Rule 10b5-1 trading plan.

Intuitive Surgical's President and Director, David J. Rosa, reported gifting 851 shares of common stock to a donor-advised fund.